Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Outstanding Traditional Chinese Medicine Vitiligo Treatment Institution Establishes Itself in Shanghai, Aiming to Provide Specialized Treatment Solutions to More International Patients


News provided by

Huahai Institute of Vitiligo Research

Sep 26, 2023, 05:00 ET

Share this article

Share toX

Share this article

Share toX

SHANGHAI, Sept. 26, 2023 /PRNewswire/ -- Recently, in a highly anticipated development, Huahai Institute of Vitiligo Research, a prominent figure in vitiligo treatment field for an impressive journey of 29 consecutive years, has unveiled a remarkable announcement: the inauguration of the Huahai Institute of Vitiligo Research in Shanghai. This significant step marks the formal expansion of the distinguished Chinese vitiligo treatment institution into key metropolitan centers.

Continue Reading

This strategic decision by Huahai Institute of Vitiligo Research not only brings the realm of TCM-based vitiligo treatment to Shanghai but also extends its influence globally. What is the rationale behind this strategic move?

Benefits for Patients:

  • Huahai Institute of Vitiligo Research's choice to establish a clinic in Shanghai eliminates the need for patients in the East China region to travel to Huahai's headquarters in Shandong for treatment. It also enables patients in and around Shanghai to access diagnostic and treatment services more conveniently, sparing them the need to journey to other cities or countries.
  • Shanghai as a top-tier city in China, boasts a wealth of medical resources and talents. It also serves as a focal point for international residents and a pivotal transit hub. Huahai's bilingual clinic caters to international patients and those with specialized treatment needs, offering them more accessible access to traditional Chinese medicine and a high caliber of medical care. Furthermore, Huahai has meticulously designed the patient experience at their Shanghai clinic, encompassing pre-diagnosis, treatment, and post-treatment phases, thus enhancing patient willingness to cooperate and improving the overall treatment experience and recovery.

Expanding International Perspective:

  • This decision underscores Huahai Institute of Vitiligo Research's global vision and international treatment philosophy. Shanghai, as an international metropolis, attracts patients and medical professionals from all over the world, fostering collaboration and research in the field of vitiligo treatment. This will further elevate Huahai's reputation and influence on the global medical stage, providing more advanced treatment options for vitiligo patients in China and worldwide.

Below are the key highlights of this Shanghai expansion. How does Shanghai's population density contribute to enhancing patient services and meeting medical demands? How have industry reputation and treatment efficacy become pivotal factors in attracting patients? How does the escalating demand for vitiligo treatment in the international market influence Huahai Institute of Vitiligo Research's decisions? And how has the " Co-treatment of melanin and vitiligo " philosophy garnered industry acclaim and support, offering patients more confidence in their treatment choices?

1. Population Density and the Trend Toward a Younger Patient Base:

Huahai Institute of Vitiligo Research's decision to establish a presence in Shanghai is intricately tied to population density. Shanghai, as a first-tier city in China, boasts a massive population. According to data from a third-party research organization, Shanghai's permanent population has exceeded 25 million. The prevalence rate of vitiligo ranges between 0.1% to 2%, providing Huahai with a broad demographic base of patients.

Furthermore, vitiligo is more common among young adults and adolescents, often correlated with the stress and irregular lifestyles of this age group. Shanghai's extensive patient base includes a significant proportion of young individuals, making the city an ideal location for Huahai's services.

It is evident that Huahai Institute of Vitiligo Research's entry into Shanghai is likely just the initial step in their expansion plan, with potential future markets in cities within and outside China that share similar characteristics, such as Guangzhou, Shenzhen, Chongqing, Tokyo, and Singapore.

2. Venturing into Top-tier Markets: What Sets Huahai Apart?

Our research reveals that Huahai Institute of Vitiligo Research, a long-established heavyweight in the field of vitiligo treatment since its founding in 1994, has amassed an impressive 29-year history of development. In this field, it is challenging to find an institution with a longer history, whether in public tertiary hospitals or regional private institutions. Titles such as "China's Only Secondary Class-A Vitiligo Specialized Institution," "16 Vitiligo Medical Publications " and the inclusion of the " Co-treatment of melanin and vitiligo " technique in national promotion in 2009, all testify to Huahai's outstanding achievements in this field.

3. Can Vitiligo Be Cured?

Through our investigations, we have uncovered numerous recovery cases of vitiligo patients, numbering in the hundreds of thousands and hailing from over 120 countries. Huahai Institute of Vitiligo Research has categorized vitiligo into various subtypes based on the location of depigmentation, including segmental subtype and non-segmental subtype. Regardless of the subtype, Huahai Institute of Vitiligo Research has numerous recovery cases to match. By examining the treatment progress of these cases, patients can gain insights into their own recovery timelines and prospects.

4. The Rise in International Market Demand:

Vitiligo is an ideal condition for traditional Chinese medicine treatment. Thanks to Huahai Institute of Vitiligo Research's longstanding reputation among international patients, an increasing number of global patients are coming to China in search of Huahai's treatment solutions. In response to this trend, the establishment of the Huahai Institute of Vitiligo Research in Shanghai, along with upgraded facilities for international patients at the institution's headquarters, demonstrates Huahai Institute of Vitiligo Research's commitment to provide convenient specialized treatment services for international patients. Huahai Institute of Vitiligo Research believes that choosing Shanghai, an international city, will help meet the growing international market demand.

Huahai Institute of Vitiligo Research's decision to establish a presence in Shanghai is driven by its confidence in population density, industry reputation, international market demand, and its advanced medical solutions. This move underscores Huahai Institute of Vitiligo Research's forward-thinking approach and professionalism. We believe that the inauguration of the Huahai Institute of Vitiligo Research in Shanghai will offer high-quality treatment experiences and recovery solutions to more vitiligo patients in East China and around the world. For more details, you can visit the official website of Huahai Institute of Vitiligo Research at www.huahai-vitiligo.com

SOURCE Huahai Institute of Vitiligo Research

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.